Cure My Disease

Don't miss your cure!

 Log in / Sign up

10-year study tracks how often LunaXT breast implants break or harden

NCT ID NCT07679594

Recruiting now Disease control Sponsor: GCA (Eurosilicone) Source: ClinicalTrials.gov ↗

First seen Jul 01, 2026 · Last updated Jul 07, 2026 · Updated 3 times

Summary

This study follows 650 women aged 18 to 65 who receive Eurosilicone LunaXT silicone breast implants for cosmetic augmentation or reconstruction after mastectomy. Researchers track how often the implants rupture or cause severe capsular contracture (hardening of scar tissue) over 10 years. The goal is to confirm the implants' real-world safety and complication rates.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Eurosilicone LunaXT silicone breast implants
What this could lead to
If the implants prove safe and durable, this could provide women with a reliable option for breast augmentation or reconstruction with fewer complications.
What could go wrong
This is an observational study, not a controlled trial, so it cannot prove the implants are better than others. Complications like rupture or capsular contracture may still occur.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST AUGMENTATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST AUGMENTATION BREAST AUGMENTATION AND BREAST RECONSTRUCTION BREAST RECONSTRUCTION BREAST RECONSTRUCTION WITH SILICONE IMPLANTS BREAST RECONSTRUCTION, REVISION BREAST RECONSTRUCTION BREAST REVISION-AUGMENTATION

Contacts and locations

Locations

  • DScultp Clinic

    RECRUITING

    Barcelona, Spain

    Contact Email: •••••@•••••

  • Dr Guillaume Lasserre

    RECRUITING

    Villefranche-sur-Saône, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.